Cardiac sarcoidosis and giant cell myocarditis after COVID‐19 infection
Entela Bollano,Christian Lars Polte,Mikko I. Mäyränpää,Anders Oldfors,Niklas Bergh,Jukka Y. A. Lehtonen,Riina Kandolin +6 more
TLDR
Four patients infected with SARS‐CoV‐2 presenting with symptomatic cardiac sarcoidosis or giant cell myocarditis 1–8 months after mild COVID‐19 are reported, which might suggest that CO VID‐19 could be a trigger for granulomatousMyocarditis.Abstract:
Patients infected with SARS‐CoV‐2 have varying manifestations of cardiac involvement. We report four patients presenting with symptomatic cardiac sarcoidosis (CS) or giant cell myocarditis (GCM) 1–8 months after mild COVID‐19. All patients received immunosuppressive therapy and improved gradually within the following months. The possible temporal association between the CS/GCM and COVID‐19 infection might suggest that COVID‐19 could be a trigger for granulomatous myocarditis.read more
Citations
More filters
Journal ArticleDOI
Cardiac magnetic resonance -detected myocardial injury is not associated with long-term symptoms in patients hospitalized due to COVID-19
Aria Yar,Valtteri Uusitalo,Satu Vaara,Miia Holmström,Aino-Maija Vuorinen,Tiina Heliö,Riitta Paakkanen,Sari Kivistö,Suvi Syväranta,Johanna Hästbacka +9 more
TL;DR: In this article , the authors studied the prevalence of post-acute myocardial scar on cardiac magnetic resonance imaging (CMR) in patients hospitalized due to coronavirus disease 2019 and its association with long-term symptoms.
Journal ArticleDOI
Clinical outcome of established diagnostic and treatment modalities of COVID-19-associated myocarditis: a systematic review
Pahel Agarwal,Roopeessh Vempati,Deekshitha Alla,Kavya Balusu,Krish Patel,Sanjana Devaragudi,Dev P Patel,Qamar Sultana,K. Paudel +8 more
TL;DR: In this paper , a systemic review of myocarditis caused by COVID-19, including clinical manifestations, diagnostic techniques, available treatments, and outcomes, is provided, where the authors emphasize the need to diagnose and timely manage myocard infections to reduce the risk of developing further complications.
References
More filters
Journal ArticleDOI
Pathological features of COVID-19-associated myocardial injury: a multicentre cardiovascular pathology study
Cristina Basso,Ornella Leone,Stefania Rizzo,Monica De Gaspari,Allard C. van der Wal,Marie Christine Aubry,Melanie C. Bois,Peter T. Lin,Joseph J. Maleszewski,James R. Stone +9 more
TL;DR: In SARS-CoV-2 there are increased interstitial macrophages in a majority of the cases and multifocal lymphocytic myocarditis in a small fraction of the Cases, and other forms of myocardial injury are also present in these patients.
Journal ArticleDOI
Detection of viral SARS-CoV-2 genomes and histopathological changes in endomyocardial biopsies.
Felicitas Escher,Heiko Pietsch,Ganna Aleshcheva,Thomas Bock,Christian Baumeier,Albrecht Elsaesser,Philip Wenzel,Christian W. Hamm,Ralph Westenfeld,Maximilian Schultheiss,Ulrich Gross,Lars Morawietz,Heinz-Peter Schultheiss +12 more
TL;DR: The novel coronavirus SARS‐CoV‐2 has spread rapidly throughout China and keeps the world in suspense, and the underlying pathophysiological mechanisms remain to be investigated.
Journal ArticleDOI
Pathological Evidence for SARS-CoV-2 as a Cause of Myocarditis: JACC Review Topic of the Week.
Rika Kawakami,Atsushi Sakamoto,Kenji Kawai,Andrea Gianatti,Dario Pellegrini,Ahmed Nasr,PA Bob Kutys,Liang Guo,Anne Cornelissen,Masayuki Mori,Yu Sato,Irene Pescetelli,Matteo Brivio,Maria Romero,Giulio Guagliumi,Renu Virmani,Aloke V. Finn +16 more
TL;DR: In this paper, a review was conducted of the published data and the authors' experience was added from autopsy examination of 16 patients dying of SARS-CoV-2 infection.
Journal ArticleDOI
Prospective Case-Control Study of Cardiovascular Abnormalities 6 Months Following Mild COVID-19 in Healthcare Workers.
George Joy,Jessica Artico,Hibba Kurdi,Andreas Seraphim,Clement Lau,George Thornton,Marta Fontes Oliveira,Robert Adam,Nikoo Aziminia,Katia Menacho,Liza Chacko,James T Brown,Rishi K Patel,Hunain Shiwani,Anish N Bhuva,João B Augusto,Mervyn Andiapen,Áine McKnight,Mahdad Noursadeghi,Iain Pierce,Timothée Evain,Gabriella Captur,Rhodri H. Davies,John P Greenwood,Marianna Fontana,Peter Kellman,Erik B. Schelbert,Thomas A. Treibel,Charlotte Manisty,James C. Moon,James C. Moon,COVIDsortium Investigators +31 more
TL;DR: In this paper, the authors detect cardiovascular changes after mild severe acute respiratory syndrome coronavirus 2 infection using magnetic resonance imaging (MRI) and blood biomarkers, with seroconversion in 21.5% of seropositive and seronegative individuals.
Journal ArticleDOI
Molecular Detection of SARS-CoV-2 Infection in FFPE Samples and Histopathologic Findings in Fatal SARS-CoV-2 Cases.
Miroslav Sekulic,Miroslav Sekulic,Holly Harper,Holly Harper,Behtash Ghazi Nezami,Behtash Ghazi Nezami,Daniel L Shen,Daniel L Shen,Simona Pichler Sekulic,Simona Pichler Sekulic,Aaron T Koeth,Clifford V. Harding,Clifford V. Harding,Hannah Gilmore,Hannah Gilmore,Navid Sadri,Navid Sadri +16 more
TL;DR: In this paper, the authors report methods and findings of 2 autopsies with molecular evaluation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) positive individuals.
Related Papers (5)
Delayed-onset myocarditis following COVID-19.
Retesh Bajaj,Hannah C Sinclair,Kush Patel,Ben Low,Ana Pericao,Charlotte Manisty,Oliver P Guttmann,Filip Zemrak,Owen Miller,Paula Longhi,Alastair G. Proudfoot,Boris Lams,Sangita Agarwal,Federica M. Marelli-Berg,Simon Tiberi,Teresa Cutino-Moguel,Gerry Carr-White,Saidi A Mohiddin,Saidi A Mohiddin +18 more
Is Myocarditis a Disease of the COVID-19 Pandemic? A Comparison of COVID-19 vs COVID-19 Vaccine-Associated Myocarditis
Patricia B. Crane,A. Lim,C. Wong +2 more